GMP requirements and standards govern the production of sterile pharmaceutical products to ensure quality, consistency, safety and sterility. Sterile areas where these products are manufactured must tightly control particles and other environmental factors. They are classified into grades A through D depending on their risk of contamination during production activities such as component preparation, product filling, and terminal sterilization. Personnel, facilities, equipment and processes must all be carefully designed, operated and maintained to minimize any risk of microbial contamination and to uphold stringent sterility standards.
This presentation contains general guidelines and basic requirements of manufacturing of sterile medicinal products. This presentation is useful for training to the people involved in manufacturing of sterile pharmaceuticals or medicines.
Designing of aseptic area, laminar flow equipment: Study of different source ...Ms. Pooja Bhandare
Designing of aseptic area, laminar flow equipment: Study of different source of contamination in aseptic area and methods of prevention, clean area classification. PHARMACEUTICALMICROBIOLOGY (BP303T)Unit-IVPart-1
Introduction: Designing of Aseptic Area . i) The clean-up area,
ii) The compounding area,
iii) The aseptic area,
iv) The quarantine area and
v) The packaging/labelling area.
Flow diagram of aseptic area. Floors, walls and ceilings, Doors, windows and services Personnel and protective clothing Cleaning and disinfection. Air Supply. Laminar flow equipment. Vertical laminar air flow bench
Horizontal laminar air flow bench
High Efficiency Particulate Air (HEPA) Filter. Operating Instructions Uses of Laminar Air Flow.Advantages of Laminar Air Flow.Limitations of Laminar Air Flow. Air flow pattern Unidirectional airflow
Non-unidirectional airflow
Combined airflow
Different Sources of Contamination in an Aseptic Area
1) Personnel:
2) Buildings and Facilities
3) Equipment and Utensils:
4) Raw Materials
5) Manufacturing Process:
Methods of Prevention of Contamination Clean Area Classification
This presentation contains general guidelines and basic requirements of manufacturing of sterile medicinal products. This presentation is useful for training to the people involved in manufacturing of sterile pharmaceuticals or medicines.
Designing of aseptic area, laminar flow equipment: Study of different source ...Ms. Pooja Bhandare
Designing of aseptic area, laminar flow equipment: Study of different source of contamination in aseptic area and methods of prevention, clean area classification. PHARMACEUTICALMICROBIOLOGY (BP303T)Unit-IVPart-1
Introduction: Designing of Aseptic Area . i) The clean-up area,
ii) The compounding area,
iii) The aseptic area,
iv) The quarantine area and
v) The packaging/labelling area.
Flow diagram of aseptic area. Floors, walls and ceilings, Doors, windows and services Personnel and protective clothing Cleaning and disinfection. Air Supply. Laminar flow equipment. Vertical laminar air flow bench
Horizontal laminar air flow bench
High Efficiency Particulate Air (HEPA) Filter. Operating Instructions Uses of Laminar Air Flow.Advantages of Laminar Air Flow.Limitations of Laminar Air Flow. Air flow pattern Unidirectional airflow
Non-unidirectional airflow
Combined airflow
Different Sources of Contamination in an Aseptic Area
1) Personnel:
2) Buildings and Facilities
3) Equipment and Utensils:
4) Raw Materials
5) Manufacturing Process:
Methods of Prevention of Contamination Clean Area Classification
Aseptic Area and Microbial Control. - Pharmaceutical Microbiology (SYBpharm) ...Kiran Shinde
Prof.Mr.Kiran K. Shinde (M.Pharm), Assistant professor (VNIPRC)
Pharmaceutical microbiology (Second year b.pharm) (3rd semester)
Introduction to Aseptic area & room
Designing of Aseptic Room
Laminar Airflow Equipment
Sources of Contamination & Method of Prevention
Classification of Aseptic Area-Room
Testing of Clean Aseptic Room
Aseptic / sterile- “ A state of control attained by using an aseptic work area and performing activities in a manner that precludes microbiological contamination of the exposed sterile product”
MANUFACTURING OF PARENTRALS
1. Formulation and Raw Materials:
Concept: The process begins with the formulation of the parenteral drug, determining its composition and concentration.
Raw Materials: High-quality pharmaceutical-grade raw materials, including active pharmaceutical ingredients (APIs), excipients, and solvents, are selected based on their compatibility and purity.
2. Sterilization of Raw Materials:
Concept: Due to the sterile nature of parenteral products, all raw materials, including the API and excipients, must undergo rigorous sterilization.
Methods: Common sterilization methods include autoclaving, filtration, and aseptic processing to ensure aseptic conditions throughout the manufacturing process.
3. Manufacturing Process:
Preparation: The formulation is prepared, and various components are weighed and measured precisely.
Mixing: The ingredients are mixed under controlled conditions to achieve a homogeneous blend, ensuring uniform distribution of the API and other components.
Filtration: The solution is then filtered to remove any particulate matter and ensure clarity.
Filling: The sterile drug solution is filled into vials, ampoules, or other suitable containers in a controlled environment, maintaining sterility.
4. Sterilization of Final Product:
Terminal Sterilization: The final product, in its container, undergoes terminal sterilization methods like autoclaving or gamma irradiation to eliminate any microbial contamination that may have occurred during the manufacturing process.
Aseptic / sterile - “ A state of control attained by using an aseptic work area and performing activities in a manner that precludes microbiological contamination of the exposed sterile product”
Validation of aseptic process should be designed to provide assurance through appropriate testing that all phases and activities of the process remain sterile and it is controlled within the predetermined parameters.
Drug product, container, and closure are subject to sterilization separately, and then brought together.
University Institute of Pharmaceutical Sciences is a flag bearer of excellence in Pharmaceutical education and research in the country. Here is another initiative to make study material available to everyone worldwide. Based on the new PCI guidelines and syllabus here we have a presentation dealing with "Aseptic requirements for parenteral products".
Thank you for reading.
Hope it was of help to you.
UIPS,PU team
Aseptic Area and Microbial Control. - Pharmaceutical Microbiology (SYBpharm) ...Kiran Shinde
Prof.Mr.Kiran K. Shinde (M.Pharm), Assistant professor (VNIPRC)
Pharmaceutical microbiology (Second year b.pharm) (3rd semester)
Introduction to Aseptic area & room
Designing of Aseptic Room
Laminar Airflow Equipment
Sources of Contamination & Method of Prevention
Classification of Aseptic Area-Room
Testing of Clean Aseptic Room
Aseptic / sterile- “ A state of control attained by using an aseptic work area and performing activities in a manner that precludes microbiological contamination of the exposed sterile product”
MANUFACTURING OF PARENTRALS
1. Formulation and Raw Materials:
Concept: The process begins with the formulation of the parenteral drug, determining its composition and concentration.
Raw Materials: High-quality pharmaceutical-grade raw materials, including active pharmaceutical ingredients (APIs), excipients, and solvents, are selected based on their compatibility and purity.
2. Sterilization of Raw Materials:
Concept: Due to the sterile nature of parenteral products, all raw materials, including the API and excipients, must undergo rigorous sterilization.
Methods: Common sterilization methods include autoclaving, filtration, and aseptic processing to ensure aseptic conditions throughout the manufacturing process.
3. Manufacturing Process:
Preparation: The formulation is prepared, and various components are weighed and measured precisely.
Mixing: The ingredients are mixed under controlled conditions to achieve a homogeneous blend, ensuring uniform distribution of the API and other components.
Filtration: The solution is then filtered to remove any particulate matter and ensure clarity.
Filling: The sterile drug solution is filled into vials, ampoules, or other suitable containers in a controlled environment, maintaining sterility.
4. Sterilization of Final Product:
Terminal Sterilization: The final product, in its container, undergoes terminal sterilization methods like autoclaving or gamma irradiation to eliminate any microbial contamination that may have occurred during the manufacturing process.
Aseptic / sterile - “ A state of control attained by using an aseptic work area and performing activities in a manner that precludes microbiological contamination of the exposed sterile product”
Validation of aseptic process should be designed to provide assurance through appropriate testing that all phases and activities of the process remain sterile and it is controlled within the predetermined parameters.
Drug product, container, and closure are subject to sterilization separately, and then brought together.
University Institute of Pharmaceutical Sciences is a flag bearer of excellence in Pharmaceutical education and research in the country. Here is another initiative to make study material available to everyone worldwide. Based on the new PCI guidelines and syllabus here we have a presentation dealing with "Aseptic requirements for parenteral products".
Thank you for reading.
Hope it was of help to you.
UIPS,PU team
CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdfSachin Sharma
This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
Welcome to Secret Tantric, London’s finest VIP Massage agency. Since we first opened our doors, we have provided the ultimate erotic massage experience to innumerable clients, each one searching for the very best sensual massage in London. We come by this reputation honestly with a dynamic team of the city’s most beautiful masseuses.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
India Clinical Trials Market: Industry Size and Growth Trends [2030] Analyzed...Kumar Satyam
According to TechSci Research report, "India Clinical Trials Market- By Region, Competition, Forecast & Opportunities, 2030F," the India Clinical Trials Market was valued at USD 2.05 billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 8.64% through 2030. The market is driven by a variety of factors, making India an attractive destination for pharmaceutical companies and researchers. India's vast and diverse patient population, cost-effective operational environment, and a large pool of skilled medical professionals contribute significantly to the market's growth. Additionally, increasing government support in streamlining regulations and the growing prevalence of lifestyle diseases further propel the clinical trials market.
Growing Prevalence of Lifestyle Diseases
The rising incidence of lifestyle diseases such as diabetes, cardiovascular diseases, and cancer is a major trend driving the clinical trials market in India. These conditions necessitate the development and testing of new treatment methods, creating a robust demand for clinical trials. The increasing burden of these diseases highlights the need for innovative therapies and underscores the importance of India as a key player in global clinical research.
3. What is GMP
• GMP, which stands for Good Manufacturing Practices, is a set of rules and
standards that govern how pharmaceutical products are made. It includes
specifications for ensuring quality, consistency, and safety in the
development, manufacturing, and distribution of medicines. GMP was
designed to ensure that safe and effective drugs are produced for patients. It
also helps ensure that patients get the right drug at the right dose, with the
right side effects, and using the right manufacturing process.
4. what is sterile area
• Sterile area is the clean room in which the concentration of airborne particle is controlled,
and is constructed and used in a manner to minimize the introduction, generation and
retention of particles inside the clean room and in which the other relevant parameters e.g.,
Temperature, Humidity and Pressure are controlled as necessary.
• Clean rooms are fitted with HEPA filters and dehumidifier systems to allow preparation of
pharmaceutical products in a moisture free and contamination free environment.
• sterile means having an entire absence of viable microorganisms or organisms that have the
potential to reproduce. No life at all like (bacteria, fungi, and viruses)
• Sterile is basically, the surface and product contact part that is free from microbial
contamination. The products that are free from all pathogens and microorganisms are called
sterile products, small volume parenteral, and large volume parenteral and ophthalmic
products.
• The technique used for the removal of all harmful microorganisms or pathogens is called the
sterile technique.
5. General considerations
• The production of sterile preparations should be carried out in clean areas,
entry to which should be through airlocks for personnel and/or for equipment
and materials. Clean areas should be maintained to an appropriate standard
of cleanliness and supplied with air that has passed through filters of the
required efficiency.
• The various operations of component preparation (such as those involving
containers and closures), product preparation, filling and sterilization should
be carried out in separate areas within the clean area.
6. Grades of Clean Rooms
• For the manufacture of sterile pharmaceutical preparations, four grades of clean areas are
distinguished as follows:
• •Grade A: The local zone for high-risk operations, e.g. filling and making aseptic
connections. Normally such conditions are achieved by using a unidirectional airflow
workstation. Unidirectional airflow systems should provide a homogeneous air speed of
0.36–0.54 m/s (guidance value) at a defined test position 15–30 cm below the terminal filter
or air distributor system. The velocity at working level should not be less than 0.36 m/s. The
uniformity and effectiveness of the unidirectional airflow should be demonstrated by
undertaking airflow visualization tests.
• •Grade B: In aseptic preparation and filling, this is the background environment for the Grade
A zone.
• Grades C and D: Clean areas for carrying out less critical stages in the manufacture of
sterile products or carrying out activities during which the product is not directly exposed (i.e.
aseptic connection with aseptic connectors and operations in a closed system).
7. Maximum permitted airborne particle concentrate
Maximum permitted number of particles per m3 greater than
or equal to the tabulated size
At rest
a
In operation
b
Grade 0.5 μm 5.0 μm 0.5 μm 5.0 μm
A 3 520 20 3 520 20
B 3 520 29 352 000 2 900
C 352 000 2 900 3 520 000 29 000
D 3 520 000 29 000 Not defined Not defined
8. Manufacture of sterile preparations
• Clean areas for the manufacture of sterile products are classified according to the required
characteristics of the environment. Each manufacturing operation requires an appropriate
level of environmental. Cleanliness in the operational state to minimize the risks of
particulate or microbial contamination of the product or materials being handled.
• Gowning System:
• In the manufacture of sterile drugs Gowning System is most important.
• 1)The gown must be sterilized and made of material which will not shed particles.
• 2)Everyone entering a clean or a sterile area must change gear garments and wear special
garments which includes head, musk and footwear.
• 3)The number of people must be as low as possible and restricted to authorized people.
• Environment Monitoring:
• Environmental monitoring is one of the most important tasks in the sterile department. It is a
regular check of view to take timely corrective measures for maintaining a favorable
manufacturing environment, minimizing the risk of product contamination. It is also a part of
validation exercise.
• The environmental monitoring approach is also adopted to ensure that there is no significant
risk of air borne cross-contamination.
9. • Terminally sterilized products
• Components and most products should be prepared in at least a Grade D environment to
ensure low microbial bioburden and particulate counts prior to filtration and sterilization.
Where the product is at unusual risk of microbial contamination (e.g. because it actively
supports microbial growth, must be held for a long period before sterilization, or is
necessarily processed mainly in open vessels), the preparation should generally be done in
a Grade C environment.
• The filling of products for terminal sterilization should generally be done in at least a Grade C
environment.
• Where the product is at unusual risk of contamination from the environment (e.g. because
the filling operation is slow, the containers are wide- necked or are necessarily exposed for
more than a few seconds before sealing), the filling should be done in a Grade A zone with at
least a Grade C background.
• The preparation and filling of ointments, creams, suspensions and emulsions should
generally be done in a Grade C environment before terminal sterilization.
10. • Aseptic processing
Aseptic processes is a process performed maintaining the sterility of a material that is
assembled from components ,each of which has been previously sterilized. This is acheived by
using adequate conditions and facilitates designed to prevent microbial contamination.
Aseptic processesrelies on several independent factors for thje prevention of recontamination of
previously sterilized components, it presents a higher riak of microbial contamination of the
product than terminal sterilization.
11. sterilization
• Whenever possible products intended to be sterile should be terminally sterilized by heat in
their final container. Where it is not possible to carry out terminal sterilization by heating due
to the instability of a formulation or incompatibility of a pack type (necessary to the
administration of the product, e.g. plastic eye-dropper bottles), a decision should be taken to
use an alternative method of terminal sterilization following filtration and/or aseptic
processing.
• Types of sterilization
• Sterilization can be achieved by the use of moist or dry heat, by irradiation with ionizing
radiation (noting that ultraviolet irradiation is not normally an acceptable method of
sterilization), by ethylene oxide (or other suitable gaseous sterilizing agents), or by filtration
with subsequent aseptic filling of sterile final containers. Each method has its advantages
and disadvantages. Where possible and practicable, heat sterilization is the method of
choice. In any case the sterilization process must be in accordance with the marketing and
manufacturing authorizations.
14. • PERSONNEL
Only the minimum number of personnel required should be present in clean areas; this is
particularly important during aseptic processes. As far as possible, inspections and controls
should be conducted from outside such areas.
All personnel (including those concerned with cleaning and maintenance) employed in such
areas should receive initial and regular training in disciplines relevant to the correct
manufacture of sterile products, including hygiene and the basic elements of microbiology. .
High standards of personal hygiene and cleanliness are essential and personnel involved in the
manufacture of sterile preparations should be instructed to report any conditions that may
cause the shedding of abnormal numbers or types of contaminants; periodic health checks for
such conditions are desirable. The action to be taken in respect of personnel who might be
introducing undue microbial hazards should be decided by a designated competent person.
Changing and washing should follow a written procedure designed to minimize the
contamination of clean-area clothing or the carry-through of contaminants to clean areas. The
clothing and its quality should be appropriate for the process and the grade of the working area.
It should be worn in such a way as to protect the product from contamination.
15. • Outdoor clothing should not be brought into changing rooms leading to Grade B and C
rooms. For every worker in a Grade A/B area, clean sterile (sterilized or adequately
sanitized) protective garments should be provided at each work session. Gloves should be
regularly disinfected during operations. Masks and gloves should be changed at least every
working session. Operators working in Grade A and B areas should wear sanitized goggles.
• Wrist-watches, cosmetics and jewellery should not be worn in clean areas.
• The clothing required for each grade is as follows:
• •Grade D. The hair and, where relevant, beard and moustache should be covered. Protective
clothing and appropriate shoes or overshoes should be worn. Appropriate measures should
be taken to avoid any contamination from outside the clean area.
• Clothing used in clean areas should be laundered or cleaned in such a way that it does not
gather additional particulate contaminants that can later be shed. Separate laundry facilities
for such clothing are desirable. If fibres are damaged by inappropriate cleaning or
sterilization, there may be an increased risk of shedding particles. Washing and sterilization
operations should follow standard operating procedures.
16. • Premises
• All premises should as far as possible be designed to avoid the unnecessary entry of
supervisory or control personnel. Grade A and B areas should be designed so that all
operations can be observed from outside.
• In clean areas all exposed surfaces should be smooth, impervious and unbroken to minimize
the shedding or accumulation of particles or microorganisms and to permit the repeated
application of cleaning agents and disinfectants, where used.
• False ceilings should be sealed to prevent contamination from the void space above them.
• Pipes and ducts and other utilities should be installed so that they do not create recesses,
unsealed openings and surfaces that are difficult to clean. Sanitary pipes and fittings
should be used and threaded pipe connections should be avoided.
• Sinks and drains should be avoided wherever possible and should be excluded from
Grade A and B areas where aseptic operations are carried out. Where installed they should
be designed, located and maintained so as to minimize the risks of microbial contamination;
they should be fitted with effective, easily cleanable traps and with air breaks to prevent
backflow. Any floor channels should be open and easily cleanable and be connected to
drains outside the area in a manner that prevents the ingress of microbial contaminants
17. .
• Changing rooms should be designed as airlocks and used to provide physical separation of
the different stages of changing and so minimize microbial and particulate contamination of
protective clothing. They should be flushed effectively with filtered air. The final stage of the
changing room should, in the at-rest state, be the same grade as the area into which it leads.
The use of separate changing rooms for entering and leaving clean areas is sometimes
desirable. In general hand-washing facilities should be provided only in the first stage of the
changing rooms.
• There should not be a change of more than one grade between airlocks or passages and
changing rooms, i.e. a Grade D passage can lead to a Grade C airlock, which leads to a
Grade B changing room, which leads to a Grade B clean room. Changing rooms should be
of a sufficient size to allow for ease of changing. Changing rooms should be equipped with
mirrors so that personnel can confirm the correct fit of garments before leaving the changing
room.
• Airlock doors should not be opened simultaneously. An interlocking system and a visual
and/or audible warning system should be operated to prevent the opening of more than one
door at a time.
18. • A filtered air supply should be used to maintain a positive pressure and an airflow relative to
surrounding areas of a lower grade under all operational conditions; it should flush the area
effectively. Adjacent rooms of different grades should have a pressure differential of
approximately 10–15 Pascals (guidance value). Indicators of pressure differentials should be
fitted between areas where this difference is important, and the pressure differentials should
be regularly recorded and failure alarmed.
• Consideration should be given to restricting unnecessary access to critical filling areas, e.g.
Grade A filling zones, by means of a physical barrier.
19. • Equipment
• Whenever possible, equipment used for processing sterile products should be chosen so
that it can be effectively sterilized by steam or dry heat or other methods.
• As far as possible, equipment fittings and services should be designed and installed so that
operations, maintenance and repairs can be carried out outside the clean area. Equipment
that has to be taken apart for maintenance should be re-sterilized after complete reassembly,
wherever possible.
• When equipment maintenance is carried out within a clean area, clean instruments and
tools should be used and the area should be cleaned and disinfected again, where
appropriate, before processing recommences, if the required standards of cleanliness and/or
asepsis have not been maintained during the maintenance work.
• All equipment such as sterilizers, air-handling and filtration systems, air vent and gas filters,
water treatment, generation, storage and distribution systems should be subject to validation
and planned maintenance; their return to use should be approved.
20. • References
• WHO Good Manufacturing Practices for sterile pharmaceutical products
Annex 6
• https://www.pharmaguideline.com/2012/09/gmp-for-sterile-pharmaceutical.html